These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 3047669

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Hirudin and hirudin fragments].
    Deschamps A, Samama M.
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):A49-53. PubMed ID: 1298182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological survey of recombinant hirudin.
    Markwardt F, Fink G, Kaiser B, Klöcking HP, Nowak G, Richter M, Stürzebecher J.
    Pharmazie; 1988 Mar; 43(3):202-7. PubMed ID: 3380865
    [Abstract] [Full Text] [Related]

  • 6. Comparative studies on various assays for the laboratory evaluation of r-hirudin.
    Walenga JM, Hoppensteadt D, Koza M, Pifarre R, Fareed J.
    Semin Thromb Hemost; 1991 Apr; 17(2):103-12. PubMed ID: 1771408
    [Abstract] [Full Text] [Related]

  • 7. The comeback of hirudin--an old-established anticoagulant agent.
    Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Apr; 115(1-2):10-23. PubMed ID: 2459000
    [Abstract] [Full Text] [Related]

  • 8. The direct thrombin inhibitor hirudin.
    Greinacher A, Warkentin TE.
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V, Quarzago D, Vindigni A, Di Cera E, Fontana A.
    Biochemistry; 1998 Sep 29; 37(39):13507-15. PubMed ID: 9753436
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Coagulation inhibition caused by selective thrombin blockade with hirudin].
    Klöss T, Lorenz W, Meyer U, Mittmann U, Neugebauer E, Saggau WW.
    Chir Forum Exp Klin Forsch; 1978 Sep 29; (1978):143-8. PubMed ID: 752579
    [Abstract] [Full Text] [Related]

  • 13. Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.
    Kirchhofer D, Tschopp TB, Hadváry P, Baumgartner HR.
    J Clin Invest; 1994 May 29; 93(5):2073-83. PubMed ID: 8182139
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hirudin and derivatives as anticoagulant agents.
    Markwardt F.
    Thromb Haemost; 1991 Jul 12; 66(1):141-52. PubMed ID: 1926044
    [No Abstract] [Full Text] [Related]

  • 16. From natural to synthetic multisite thrombin inhibitors.
    Lombardi A, De Simone G, Galdiero S, Staiano N, Nastri F, Pavone V.
    Biopolymers; 1999 Jul 12; 51(1):19-39. PubMed ID: 10380350
    [Abstract] [Full Text] [Related]

  • 17. [Hirudin--comeback of Hirudo medicinalis].
    Lassila R.
    Duodecim; 1992 Jul 12; 108(6):535-7. PubMed ID: 1366111
    [No Abstract] [Full Text] [Related]

  • 18. Hirudins: from leeches to man.
    Wallis RB.
    Semin Thromb Hemost; 1996 Jul 12; 22(2):185-96. PubMed ID: 8807716
    [Abstract] [Full Text] [Related]

  • 19. Comparative antithrombotic potencies of direct thrombin inhibitors and low-molecular-weight heparins in an ex vivo human experimental thrombosis model.
    Harenberg J, Zokai K, Piazolo L, Fenyvesi T, Jörg I.
    Semin Thromb Hemost; 2002 Aug 12; 28(4):379-82. PubMed ID: 12244485
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.